Margreet Veening

7PUBLICATIONS
58CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Paediatrics not elsewhere classifiedObstetrics and gynaecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 20, 2025
Nephrotoxicity Surveillance for Childhood and Young Adult Survivors of Cancer: Recommendations From the International Late Effects of Childhood Cancer Guideline Harmonization Group.

Esmee C M Kooijmans, Renée L Mulder, Stephen D Marks

|Sep 11, 2024
Semen analysis and reproductive hormones in boys with classical Hodgkin lymphoma treated according to the EuroNet-PHL-C2 protocol.

K C E Drechsel, S L Broer, H M K van Breda

|May 25, 2024
The impact of treatment for childhood classical Hodgkin lymphoma according to the EuroNet-PHL-C2 protocol on serum anti-Müllerian Hormone.

K C E Drechsel, S L Broer, F S Stoutjesdijk

|Feb 02, 2024
Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial.

Inge M van der Sluis, Leiah J Brigitha, Marta Fiocco

|Jul 31, 2023
Clinical and self-reported markers of reproductive function in female survivors of childhood Hodgkin lymphoma.

K C E Drechsel, S L Broer, F S Stoutjesdijk

|Jul 17, 2023
Improved Outcome for ALL by Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for Other Risk Groups.

Rob Pieters, Hester de Groot-Kruseman, Marta Fiocco

Pageof 2